arrow
M

Mitchell E. Horwitz

duke university
H指数:43
被引数:7,689

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sociodemographic factors and timing of allogeneic hematopoietic stem cell transplantation in myeloproliferative neoplasms

社会人口因素及异基因造血干细胞移植在骨髓增殖性肿瘤中的时间选择

2026-04-120
PRE
Impact of donor age on cognitive recovery in allogenic hematopoietic stem cell transplant patients with mild cognitive impairment

供者年龄对伴有轻度认知障碍的同种异基因造血干细胞移植患者认知恢复的影响

2026-04-040
PRE
Single-centre analysis of prophylactic dexamethasone on the incidence and severity of cytokine release syndrome and immune effector cell-associated neurotoxicity in patients receiving axicabtagene ciloleucel

预防性地塞米松对接受axicabtagene ciloleucel的患者细胞因子释放综合征和免疫效应细胞相关神经毒性的发生率和严重程度的单中心分析

2026-01-190
PRE
Hematopoietic Cell Transplantation, Version 3.2025

造血细胞移植,版本 3.2025

2025-10-011
PRE
Exploring Perspectives on Feasibility, Challenges, and Support Needs for Chlorhexidine Gluconate (CHG) Bathing in the Outpatient Setting for Hematopoietic Cell Transplant Recipients: A Qualitative Study

探索在门诊环境中为造血细胞移植受者进行葡萄糖酸洗必泰(CHG)沐浴的可行性、挑战和支持需求的观点:一项定性研究

2025-09-190
PRE
Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTR

异基因造血细胞供者选择:NMDP/CIBMTR当代指南

2025-07-010
PREAI
Understanding Sociodemographic Barriers in Hematopoietic Stem Cell Transplantation Among Patients with Hematologic Malignancies: Insights from a North Carolina Cohort

理解血液恶性肿瘤患者造血干细胞移植中的社会经济障碍:来自北卡罗来纳队列的见解

BLOOD
IF23.1
2024-11-050
PRE
Disparities in CAR-T Therapy Access and Outcomes: Variation in Referral Patterns for CAR-T Therapy in Patients with Newly Diagnosed Malignancies at an Academic Center in North Carolina

CAR-T疗法可及性与结局的不平等:在北卡罗来纳州某学术中心新诊断恶性肿瘤患者中CAR-T疗法转诊模式的差异

BLOOD
IF23.1
2024-11-050
PRE
Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 Substudy

免疫重建分析表明,使用Omidubicel移植后具有抗病毒保护作用: 一项3期子研究

2023-08-016
OAAI
Single-cell landscape analysis unravels molecular programming of the human B cell in chronic GVHD
2023-06-085
OA
Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials

异基因造血干细胞移植与omiudubicel的多中心长期随访: 五项前瞻性临床试验的汇总分析

2023-05-017
OAAI
A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease

Fostamatinib抑制SYK在预防和治疗慢性移植物抗宿主病中的I期试验

2023-03-0110
OAAI
Hematopoietic Cell Transplantation, Version 3.2022 Featured Updates to the NCCN Guidelines
2023-02-013
OA